Clinical Trial Update: Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 sequential trial of reduced-intensity conditioning allogeneic transplantation in patients with hematologic malignancies, including multipl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: European Myeloma Network B.V. | Conditions: Hematologic Malignancies, Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED